FDA Seeks Venture Capital Firm Input on New Contracting Approach

On December 19, 2025, the Food and Drug Administration (FDA), part of the US Department of Health and Human Services, released a request for information (RFI) seeking input from venture capital firms on how the FDA can better access innovative early-stage companies through creative contracting methods in order to spur advancements in public health….
By: Cooley LLP